Health-related quality of life after completion of successful treatment for childhood cancer

Background Previous studies have assessed health‐related quality of life (HRQOL) during several treatment stages in children with cancer, but there is limited knowledge about HRQOL shortly after completing therapy. This study determined HRQOL of children with cancer shortly after the end of successf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric blood & cancer 2011-04, Vol.56 (4), p.646-653
Hauptverfasser: Engelen, V., Koopman, H.M., Detmar, S.B., Raat, H., van de Wetering, M.D., Brons, P., Anninga, J.K., Abbink, F., Grootenhuis, M.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Previous studies have assessed health‐related quality of life (HRQOL) during several treatment stages in children with cancer, but there is limited knowledge about HRQOL shortly after completing therapy. This study determined HRQOL of children with cancer shortly after the end of successful treatment compared with normative values. Procedure Several age‐specific HRQOL questionnaires were administered: the ITQOL (generic, proxy‐report, 0–4 years), CHQ PF 50 (generic, proxy‐report, 5–7 years), Kidscreen (generic, self‐report, 8–18 years) and Disabkids (chronic generic, self‐report, 8–18 years). Results Children with cancer (N = 191, mean age 9.25, SD 5.06, 47.1% female) participated. Physical well‐being was affected for all ages. Compared to normative values 0‐ to 7‐year‐olds were rated significantly lower on the majority of the scales. In addition, 12‐ to 18‐year‐olds had significantly better HRQOL than the norm on social scales. Compared to chronically ill norms, 8‐ to 18‐year‐olds demonstrated no differences, except for 12‐ to 18‐year‐olds who experienced significantly more physical limitations. Additionally, we found that HRQOL of parents of 0‐ to 7‐year‐olds was poorer than the norm. Conclusion HRQOL in children with cancer and their parents can be impaired compared with the norm. Therefore, HRQOL should be monitored in clinical practice to make paediatric oncologists aware of these problems. For young children, we recommend checking whether certain HRQOL problems can be explained by parental worries. For older children and adolescents, paediatric oncologists need to consider social desirability and the child's adaptive style. Pediatr Blood Cancer 2011;56:646–653. © 2010 Wiley‐Liss, Inc.
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.22795